Moderna's South Korean Partner to Distribute 40 Million COVID-19 Vaccines

South Korea-based GC Pharma announced that it would support Moderna Inc. and the Republic of Korea's government to distribute 40 million doses of COVID-19 Vaccine Moderna.

Under the terms of its agreement with Moderna, GC pharma is responsible for local regulatory activities. Under the terms of its agreement with the Korean government, GC Pharma, with the Korean government authorities' support, is responsible for distribution activities in South Korea.

“We are proud to be partnering with the government and Moderna to support the distribution of crucial vaccines to the South Korean public,” said EC Huh, Ph.D., President of GC Pharma, in a press statement. “At GC pharma, with using our industry know-how, we are also exploring multiple ways to specifically help those impacted by COVID-19 and ensure preparedness for future public health emergencies.”

The Korea Diseases Control and Prevention Agency previously announced that it would import 40 million doses of COVID-19 Vaccine Moderna from the second quarter of 2021.

Headquartered in Yongin, South Korea, GC Pharma (formerly known as Green Cross Corporation) is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines.